Molecular biological characteristics of tumors and results of breast cancer treatment in males

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: Male breast cancer is considered a rare condition – less than 1% of all breast cancer cases. 1607 cases of breast cancer were diagnosed by 2019 in Krasnoyarsk region and only 5 cases (0,31%) of the disease were in male patients.

AIM: This study aims to conduct a retrospective analysis of cases of breast cancer treatment in males in the Krasnoyarsk Territory for the period 1998–2019, as well as to assess overall and progression-free survival rates in this category of patients.

MATERIALS AND METHODS: A total of 28 males with diagnosed breast cancer received treatment at the Krasnoyarsk Regional Clinical Oncological Dispensary named after A.I. Kryzhanovsky in the period from 1998 to 2019.

RESULTS: Since 2013, an increase in breast cancer in males is noted in the Krasnoyarsk Territory. Average age of the patients at the time of diagnosis was 60.3±10.3 (range – 35 to 83 years). Allocating patients to the clinical stages: 8 patients (28.6%) were diagnosed with stage I of the tumor process, stage II was revealed in 12 (42.9%) patients, stage III was diagnosed in 7 (24.9%) patients and in 1 case (3.6%) cancer was found in situ. Metastatic lesions of the lymph nodes were revealed in 11 patients (39.3%): N1 – 9 patients (81.8%), N2 – 1 patient (9.1%), N3 – 1 patient (9.1%). Luminal A subtype was diagnosed in 3 patients (13.6%), luminal B (HER2-negative) – in 16 patients (72.8%), luminal B (HER2-positive) – in 2 patients (9.1%). 75% of patients received adjuvant therapy. As a result of the treatment, stabilization of the process was registered in 64.3% of cases. 4 patients (14.3%) suffered from recurrence of the disease; 2 patients (7.1%) were diagnosed with multiple primary cancer. For the entire observation period, fatal cases composed 4 (14.3%). Analysis of the overall survival rates for the male patients with breast cancer demonstrated a positive effect of endocrine therapy.

CONCLUSION: The results obtained indicate an increase in the incidence of breast cancer in men in the Krasnoyarsk Territory. Men have the tumor which is hormone-positive and administration of hormone therapy in the adjuvant mode increases overall survival rates.

About the authors

Alena V. Zyuzyukina

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Author for correspondence.
Email: alena-vz@mail.ru
ORCID iD: 0000-0002-6758-4800
SPIN-code: 6663-3600
Russian Federation, zd. 1, ul. Partizana Zheleznjaka, Krasnojarsk, Krasnojarskij kraj, 660022

Evgeniy V. Slepov

Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovsky

Email: slepov99@mail.ru
ORCID iD: 0000-0002-3787-3126
SPIN-code: 2097-0304

MD, Cand. Sci. (Biol.)

Russian Federation, Krasnoyarsk

Yury S. Vinnik

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: yuvinnik@yandex.ru
ORCID iD: 0000-0002-8995-2862
SPIN-code: 5070-8140

MD, Dr. Sci. (Med.), Professor

Russian Federation, zd. 1, ul. Partizana Zheleznjaka, Krasnojarsk, Krasnojarskij kraj, 660022

Ruslan A. Zukov

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky; Krasnoyarsk Regional Clinical Oncology Center named after A.I. Kryzhanovsky

Email: zukov.ra@krasgmu.ru
ORCID iD: 0000-0002-7210-3020
SPIN-code: 3632-8415
Russian Federation, zd. 1, ul. Partizana Zheleznjaka, Krasnojarsk, Krasnojarskij kraj, 660022; Krasnoyarsk

References

  1. Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(10):1674. doi: 10.1093/annonc/mdz189
  2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492
  3. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24(6):1434–1443. doi: 10.1093/annonc/mdt025
  4. Brinton LA, Carreon JD, Gierach GL, et al. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 2010;119(1):185–192. doi: 10.1007/s10549-009-0379-0
  5. Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28(12):2114–2122. doi: 10.1200/JCO.2009.25.5729
  6. Abrahams HJG, Knoop H, Schreurs M, et al. Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses. Psychooncology. 2020;29(11):1772–1785. doi: 10.1002/pon.5522
  7. Keinan-Boker L, Levine H, Leiba A, et al. Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men. Int J Cancer. 2018;142(5):910–918. doi: 10.1002/ijc.31121
  8. Massarweh SA, Sledge GW, Miller DP, et al. Molecular Characterization and Mortality From Breast Cancer in Men. J Clin Oncol. 2018;36(14):1396–1404. doi: 10.1200/JCO.2017.76.8861
  9. Tynes T, Andersen A. Electromagnetic fields and male breast cancer. Lancet. 1990;336(8730):1596. doi: 10.1016/0140-6736(90)93387-5
  10. Rosenbaum PF, Vena JE, Zielezny MA, Michalek AM. Occupational exposures associated with male breast cancer. Am J Epidemiol. 1994;139(1):30–36. doi: 10.1093/oxfordjournals.aje.a116932
  11. Hoffman A, Ben Ishay O, Horesh N, et al. Breast Cancer in Men: A Single Center Experience Over a Period of 22 years. Isr Med Assoc J. 2020;22(3):160–163.
  12. Pan H, Zhang K, Wang M, et al. The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population-based observational study. Cancer. 2020;126 Suppl 16:3830–3836. doi: 10.1002/cncr.32829
  13. Cardoso F, Bartlett JMS, Slaets L, et al. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29(2):405–417. doi: 10.1093/annonc/mdx651
  14. Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother. 2007;8(2):193–202. doi: 10.1517/14656566.8.2.193

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Yearly distribution of male breast cancer cases in Krasnoyarsky kray

Download (115KB)
3. Fig. 2. Overall survival rates in male patients with breast cancer

Download (112KB)
4. Fig. 3. Progression-free survival rates in male patients with breast cancer

Download (114KB)

Copyright (c) 2021 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies